18 years track record in healthcare, both in the UK and Internationally. Founding member and former leader of Oliver Wyman’s international healthcare team. Extensive knowledge of day surgery clinical models. Experience on the front line of UK private and NHS care, as well in the policy space at the highest level in government.

18 years' investment banking and capital markets experience in London. Specialised in capital structuring and fundraising. Joined Welbeck Health Partners in July 2022.

10 years in healthcare consulting for Oliver Wyman. Led numerous development and strategy engagements across NHS, private providers, international and pharma clients. Developed original AmSurg international build plan during time at Welbeck. Supported one of the pioneering clinical care model transformation projects in the UK NHS.

8 year's experience launching and scaling joint venture clinician partnerships at WHP. Responsible for business performance of operating partnerships including doctor partner engagement and development and execution of growth strategies. Responsible for the launch of new partnerships including advising on multi-million-pound capital project business cases, set up road maps, clinician partnership engagement strategies, facility and operational pathways design, and staffing model development.

Over 25 years experience in consulting including HR strategy. Led global teams in the fields of talent analytics, learning and development and recruiting. Holds a PhD in geochemistry.

Professor of Cardiology, Imperial College Healthcare NHS Trust & Imperial College London. Chair, National Institute for Health and Care Research, Cardiovascular-Covid Health Informatics Collaborative. Previously, Executive Director, Imperial Healthcare NHS Trust, leading the Surgery, Cancer & Cardiovascular Division. Previously, Head of Cardiovascular Division, National Heart & Lung Institute.

Senior Consultant Gastroenterologist, co-founder of Welbeck Endoscopy Centre. Specialises in colonoscopy, colon cancer screening, abdominal pain, and inflammatory bowel disease. Expert endoscopist at the forefront of endoscopic research, developing new interventional therapies for obesity-related type 2 diabetes. His advice is regularly sought by professional bodies such as NICE and the Royal College of Physicians.

35 years' experience in healthcare. Professor of Cardiology, Bart's Health NHS Trust. Previously Director of Commercial & Strategy for St Bartholomew's Hospital. Chairman and Founder of Rhythm AI (manufacturer of FDA-approved medtech STAR mapping).